China National Medical Products Administration (NMPA) organized to formulate the Administrative Measures for Sampling Inspection of Cosmetics, which was issued on January 12, 2023, and shall come into force on March 1, 2023.
The Measures has 8 chapters and 61 articles, which define the rights, obligations, processes, time limits, and other requirements of the regulatory authorities, inspection agencies, and producers and operators in the work related to sampling inspection. It strengthens the requirements for the inspection and disposal of non-conforming products, and emphasizes the protection of the legitimate rights and interests of producers and operators, helping to improve the quality and safety management level of cosmetics.
1. The Measures stipulate that children's cosmetics, special cosmetics, cosmetics using new ingredients, products with many problems in previous supervision, products with high failure rate in previous sampling inspection, products with a wide circulation range, products with high frequency of use and other products with high safety risks shall be the focus of sampling inspection.
2. The Measures strengthen the supervision of online sales of cosmetics and determine the form and requirements of online sampling inspection for the first time.
3. The Measures clearly explain the abnormal condition of sampling inspection: 1) special cosmetics without registration or general cosmetics that have not completed filing for sale and import; 2) Exceeding the shelf life; 3) No Chinese label; 4) The label marked with prohibited contents; 5) Other cosmetics suspected to be illegal. In case of any abnormal sampling, the sampling unit shall file an investigation or notify the department responsible for drug supervision according to law.
4. The Measures define the procedures, time limits, and requirements for the whole process of sampling inspection, and strive to reduce the burden of enterprises and protect their legitimate rights and interests from multiple aspects such as sampling inspection, disposal, and information disclosure.